Savara Downgraded at Evercore on Manufacturing Concerns for Lung Disease Candidate

Seeking AlphaNov 13 23:58

Savara Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 13 22:53 · Ratings

Oppenheimer Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $15

Futu NewsNov 13 21:36 · Ratings

Oppenheimer Keeps Their Buy Rating on Savara (SVRA)

TipRanksNov 13 21:08 · Ratings

Savara Announces Participation in Upcoming Healthcare Conferences

BusinesswireNov 13 21:05

H.C. Wainwright Maintains Savara(SVRA.US) With Buy Rating, Cuts Target Price to $6

Futu NewsNov 13 20:31 · Ratings